The purpose of the funding opportunity is to expand and advance FDA's Office of Minority Health and Health Equity (OMHHE) work with stakeholders and partners for education, outreach, and public awareness activities on potential risks from skin lightening products containing hydroquinone and/or mercury.
Applicants will research and propose innovative and community-based strategies and activities that have the potential to strengthen the science base for education and public health awareness on the use of and potential risks from over-the-counter (OTC) skin lightening products.
Deadlines:
-
Letter of Intent Due Date(s): Jan. 1, 2024
-
Application Due Date(s): Feb. 29, 2024
RFA-FD-24-023 Expiration Date March 1, 2024